VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LUNG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LUNGPulmonx Corporation
$2.56$108M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLUNGBalance Sheet

Pulmonx Corporation (LUNG) Balance Sheet

8Y historyFree accessUpdated daily

Total debt has held near $56M while equity shrank to $34.2M, lifting the debt-to-equity ratio from 0.56 to 1.65, which suggests leverage risk is rising as the equity cushion erodes.

Income StatementBalance SheetCash FlowRatios

LUNG Balance Sheet

Annual statement

LUNG Balance Sheet

Pulmonx Corporation (LUNG) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets84.06M101.68M136.25M150.42M168.95M208M249.99M41.07M11.31M
Cash & Short-Term Investments52.69M70.01M101.48M117.1M141.14M180.04M231.79M28.35M4.12M
Cash Only52.69M70.01M70.91M83.55M101.74M148.48M231.79M14.77M4.12M
Short-Term Investments0030.58M33.55M39.4M31.56M013.58M0
Accounts Receivable12.01M12.07M13.79M13.02M9.28M6.92M4.57M6M3.42M
Days Sales Outstanding48.9348.6960.0869.263.1152.250.9367.1762.42
Inventory15.44M15.85M16.91M16.74M14.56M16.29M10.74M5.61M3.32M
Days Inventory Outstanding291.2247.6283.37340.97385.29464.89339.99201.2157.01
Other Current Assets3.92M3.76M1.39M741K521K578K377K666K125K
Total Non-Current Assets26.15M27.61M26.6M27.36M24.72M27.17M13.72M12.46M3.71M
Property, Plant & Equipment18.8M20.25M21.45M7.43M10.5M12.89M10.45M7.46M375K
Fixed Asset Turnover4.56x4.47x3.91x9.24x5.11x3.76x3.13x4.37x53.34x
Goodwill2.33M2.33M2.33M2.33M2.33M2.33M2.33M2.33M2.33M
Intangible Assets0700K031K154K277K400K524K647K
Long-Term Investments00014.39M5.92M10.94M000
Other Non-Current Assets5.02M4.33M2.82M3.17M5.81M731K536K2.14M350K
Total Assets110.21M129.29M162.85M177.78M193.68M235.17M263.71M53.53M15.01M
Asset Turnover0.75x0.70x0.51x0.39x0.28x0.21x0.12x0.61x1.33x
Asset Growth %-83.37%-20.61%-8.4%-8.21%-17.65%-10.82%392.61%256.58%-
Total Current Liabilities20.74M20.06M24.44M23.16M18.49M17.55M12.53M14.16M8.07M
Accounts Payable4.51M3.9M3.83M1.5M1.76M1.58M1.47M2.68M1.29M
Days Payables Outstanding75.461.0264.1130.4946.5145.1646.5996.1260.96
Short-Term Debt1.49M1.32M3.18M2.15M90K91K2.24M00
Deferred Revenue (Current)78K18K135K104K120K163K71K173K139K
Other Current Liabilities14.73M4.98M6.89M7.88M4.97M4.74M3.1M6.47M2.49M
Current Ratio4.05x5.07x5.58x6.50x9.14x11.85x19.96x2.90x1.40x
Quick Ratio3.31x4.28x4.88x5.77x8.35x10.92x19.10x2.50x0.99x
Cash Conversion Cycle264.73235.27279.33379.68401.9471.92344.32172.25158.47
Total Non-Current Liabilities55.27M55.12M52.6M36.31M21.18M24.38M25.05M226.75M174.27M
Long-Term Debt54.86M36.99M34M35.09M17.23M17.32M17.37M220.3M33.6M
Capital Lease Obligations35.8M18.06M18.52M1.11M3.85M6.84M7.62M6.4M0
Deferred Tax Liabilities274K69K87K114K94K37K62K43K48K
Other Non-Current Liabilities345K0000179K00140.61M
Total Liabilities76.01M75.17M77.04M59.47M39.67M41.93M37.57M240.91M182.34M
Total Debt56.35M56.36M56.47M41.42M24.4M26.46M27.22M227.15M33.6M
Net Debt3.66M-13.64M-14.43M-42.12M-77.33M-122.02M-204.57M212.39M29.48M
Debt / Equity1.65x1.04x0.66x0.35x0.16x0.14x0.12x--
Debt / EBITDA-1.46x--------
Net Debt / EBITDA-0.09x--------
Interest Coverage-8.99x-15.92x-14.94x-17.65x-53.94x-57.28x-9.07x-7.78x-6.33x
Total Equity34.2M54.12M85.81M118.31M154.01M193.24M226.13M-187.38M-167.33M
Equity Growth %-164.31%-36.93%-27.47%-23.18%-20.3%-14.55%220.68%-11.98%-
Book Value per Share0.791.332.193.124.155.356.34-5.29-8.08
Total Shareholders' Equity34.2M54.12M85.81M118.31M154.01M193.24M226.13M-187.38M-167.33M
Common Stock44K42K40K39K38K37K36K19K17K
Retained Earnings-553.69M-521.56M-467.56M-411.16M-350.32M-291.39M-242.73M-210.5M-189.8M
Treasury Stock000000000
Accumulated OCI1.72M2.36M2.11M2.64M1.57M1.71M1.69M1.37M1.33M
Minority Interest000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityWeak
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Shrinking equity cushion against losses

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Equity Eroding Under Sustained Losses

Based on Pulmonx's reported balance sheet, total equity fell from $101.2M in 2024Q2 to $34.2M in 2026Q3, a decline of roughly 66% as the accumulated deficit grew to $553.7M over the same ten quarters.

The balance sheet is weakening rather than stabilizing, with equity compressing at a pace that broadly tracks the recurring operating losses reported in the income statement. Equity erosion is the dominant structural change, and the remaining book value leaves a thinner buffer against further losses than the headline asset base suggests. Investors should monitor whether the rate of erosion slows as losses narrow, since the supplied data does not yet show a clear inflection.

Flat Debt Load Amplifies Leverage Ratio

Total debt has held near $56M across all ten quarters, so the reported debt-to-equity ratio climbed from 0.56 to 1.65 largely because the equity denominator shrank rather than because borrowing increased.

Because the debt balance has been essentially static, the rising D/E ratio reflects a shrinking equity base instead of a change in financing strategy, making leverage a symptom of accumulated losses. The obligations are now large relative to the book value supporting them. The supplied data does not describe debt maturity or cost, so analysts should evaluate whether operating cash flows, which remain negative, can service this load over time.

Cash Cushion Thinning Against Burn

As reported in the financial statements, cash fell from $75.5M in 2025Q2 to $52.7M in 2026Q3, while the current ratio remains elevated near 4.05, a comfort measure set against a shrinking pool of cash.

The liquidity position appears adequate in a static sense, yet the downward trend in cash balances points to a finite runway if operating cash burn persists at the levels implied by the cash flow data. A high current ratio alongside falling cash suggests current assets are being consumed rather than replenished. Analysts should treat the current ratio as a lagging indicator and focus on cash runway relative to quarterly burn.

Asset-Light Base With Minimal PPE

Based on Pulmonx's reported figures, net PP&E of roughly $19M and goodwill of $2.3M represent a small share of total assets of $110.2M in 2026Q3, indicating an asset base dominated by current items.

The asset mix reflects a business model that does not require heavy physical reinvestment, limiting capital-intensity risk but also offering little tangible collateral. Goodwill is small, so impairment risk is limited relative to the total asset base. Value therefore appears to reside mainly in working capital and cash rather than in long-lived operating assets.

Headline Current Ratio Overstates Safety

According to recent SEC filings, the current ratio of 4.05 in 2026Q3 looks robust, yet it has fallen from 8.97 in 2024Q2 as cash declined, meaning the headline liquidity metric is weakening faster than its level suggests.

A current ratio above 4 can mask a deteriorating liquidity position when the numerator is being drawn down by ongoing operating losses. The ratio's decline from 8.97 signals that the cushion is compressing even while remaining numerically high. Investors should weigh this against the persistent cash burn and the accumulated deficit, which together indicate the company's ability to absorb further shocks depends on continued access to its existing cash balance.

LUNG — Frequently Asked Questions

Quick answers to the most common questions about buying LUNG stock.

What are the total assets of Pulmonx Corporation (LUNG)?

As of 2025, Pulmonx Corporation (LUNG) had total assets of $129.3M including $101.7M in current assets.

How much debt does Pulmonx Corporation (LUNG) have?

Pulmonx Corporation (LUNG) carries total debt of $56.4M, offset by $70.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Pulmonx Corporation?

Pulmonx Corporation (LUNG) has total shareholders' equity (book value) of $54.1M ($1.33 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Pulmonx Corporation's current ratio and liquidity?

Pulmonx Corporation (LUNG) reported a current ratio of 5.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.